Skip to content

Portal vein lactate detection with a special MRI technique in patients with compromised intestinal blood flow.

Portal vein Lactate Detection in Mesenteric Ischemia by Deuterium Metabolic Imaging MRI - PLaDeMI

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON57855
Enrollment
10
Registered
2025-02-05
Start date
2025-10-20
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mesenteric ischemia

Interventions

Intervention: patients get to drink a deuterated glucose solution in water and high caloric &nbsp
chocolate milk (total energy intake 600 kcal) after which they undergo an MRI and DMI scans at 7 Tesla.

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with clinically proven chronic mesenteric ischemia that are scheduled for (endo)vascular surgery * 18 =< age =< 80 * Ability and willing to give informed consent * Ability to follow test instructions * Sufficient understanding of the Dutch language

Exclusion criteria

Exclusion criteria: Contra-indications to MRI examination according to 7T MRI screening guideline of the UMC Utrecht, including not being able to fit in the 7T MRIAllergic to milkAcute Mesenteric Ischemia

Design outcomes

Primary

MeasureTime frame
The main study parameters are 3D DMI measurements of deuterated glucose during gastric emptying, intestinal uptake (and partial conversion to lactate) as becomes visible in the portal vein and liver of patients suspected for CMI. A measured signal to noise ratio = 3 of lactate in the portal vein of these patients.

Secondary

MeasureTime frame
Ratio of deuterated lactate to glucose in the portal vein.

Countries

Netherlands

Contacts

Public Contactwjm Kemp

Universitair Medisch Centrum Utrecht

wkemp@umcutrecht.nl0887556674

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)